These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
70. Docking- and pharmacophore-based virtual screening for the identification of novel Mycobacterium tuberculosis protein tyrosine phosphatase B (MptpB) inhibitor with a thiobarbiturate scaffold. Zhang D; Lin Y; Chen X; Zhao W; Chen D; Gao M; Wang Q; Wang B; Huang H; Lu Y; Lu Y Bioorg Chem; 2019 Apr; 85():229-239. PubMed ID: 30641319 [TBL] [Abstract][Full Text] [Related]
71. High content screening identifies decaprenyl-phosphoribose 2' epimerase as a target for intracellular antimycobacterial inhibitors. Christophe T; Jackson M; Jeon HK; Fenistein D; Contreras-Dominguez M; Kim J; Genovesio A; Carralot JP; Ewann F; Kim EH; Lee SY; Kang S; Seo MJ; Park EJ; Skovierová H; Pham H; Riccardi G; Nam JY; Marsollier L; Kempf M; Joly-Guillou ML; Oh T; Shin WK; No Z; Nehrbass U; Brosch R; Cole ST; Brodin P PLoS Pathog; 2009 Oct; 5(10):e1000645. PubMed ID: 19876393 [TBL] [Abstract][Full Text] [Related]
72. The DprE1 enzyme, one of the most vulnerable targets of Mycobacterium tuberculosis. Riccardi G; Pasca MR; Chiarelli LR; Manina G; Mattevi A; Binda C Appl Microbiol Biotechnol; 2013 Oct; 97(20):8841-8. PubMed ID: 24037308 [TBL] [Abstract][Full Text] [Related]
73. Inhibitor binding studies of Mallavarapu BD; Abdullah M; Saxena S; Guruprasad L J Biomol Struct Dyn; 2019 Sep; 37(14):3751-3763. PubMed ID: 30239262 [TBL] [Abstract][Full Text] [Related]
74. Quinolone analogues of benzothiazinone: Synthesis, antitubercular structure-activity relationship and ADME profiling. Dube PS; Legoabe LJ; Jordaan A; Sigauke L; Warner DF; Beteck RM Eur J Med Chem; 2023 Oct; 258():115539. PubMed ID: 37321107 [TBL] [Abstract][Full Text] [Related]
75. Leads for antitubercular compounds from kinase inhibitor library screens. Magnet S; Hartkoorn RC; Székely R; Pató J; Triccas JA; Schneider P; Szántai-Kis C; Orfi L; Chambon M; Banfi D; Bueno M; Turcatti G; Kéri G; Cole ST Tuberculosis (Edinb); 2010 Nov; 90(6):354-60. PubMed ID: 20934382 [TBL] [Abstract][Full Text] [Related]
76. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis. Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494 [TBL] [Abstract][Full Text] [Related]
77. Identification of Antimycobacterial Agent Using In Silico Virtual Screening, ADME Prediction, Docking, and Molecular Dynamics Simulations Approach. Tripathy S; Sahu SK; Azam MA; Jupudi S; Gupta VK; Sharma S Curr Comput Aided Drug Des; 2021; 17(6):806-816. PubMed ID: 32748754 [TBL] [Abstract][Full Text] [Related]
79. 3D QSAR, Docking, Molecular Dynamics Simulations and MM-GBSA studies of Extended Side Chain of the Antitubercular Drug (6S) 2-Nitro-6- {[4-(trifluoromethoxy) benzyl] oxy}-6,7-dihydro-5H-imidazo[2,1-b] [1,3] oxazine. Chaudhari HK; Pahelkar A Infect Disord Drug Targets; 2019; 19(2):145-166. PubMed ID: 30324898 [TBL] [Abstract][Full Text] [Related]
80. Synthesis and Structural Elucidation of Novel Benzothiazole Derivatives as Anti-tubercular Agents: In-silico Screening for Possible Target Identification. Venugopala KN; Chandrashekharappa S; Pillay M; Bhandary S; Kandeel M; Mahomoodally FM; Morsy MA; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K; Odhav B Med Chem; 2019; 15(3):311-326. PubMed ID: 29968540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]